Patient centricity and access highlight keys to success for new development.
Dan Schroen
Advertisement
Articles by Dan Schroen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Pharma Patent Cliff Explained: What It Is and How Companies Navigate It
2
FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer
3
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
4
FDA Sends CRL to Cingulate for CTx-1301
5